Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Kala

Five healthcare stocks have emerged as standout performers, posting remarkable week-on-week momentum gains according to the latest Benzinga Edge Ranking report.

Benzinga

Christmas gifts for musicians and aspiring rock stars

T3's guide to the best gifts for those who like to rock and or roll

The Antipodes Oladra is a high-end music server with a sky high price

The Antipodes Oladra music server costs as much as a Volkswagen Golf, but it promises life-changing performance.

What Hi-Fi?

From analysis to the latest developments in health,
read the most diverse news in one place.

Acclaimed chef's genius response to swipe that new pub 'will only last six months'

He delivered the perfect riposte to a critic

Manchester Evening News

Chef Gary Usher drops big hint over new dog friendly pub opening date

The Elite Bistros founder, which owns Hispi in East Didsbury and Kala in Manchester, became the owner of the White Horse pub back in October

Manchester Evening News

Three Greater Manchester eateries named in Top 100 Restaurants in the UK

OpenTable's annual list spotlights some of the most beloved restaurants in the UK

Manchester Evening News

Chef Gary Usher saved treasured village pub from developers who planned to knock it down and build flats

The chef behind Hispi and Kala will open The White Horse in Churton

Manchester Evening News

Read news from The Economist, FT, and more,
with one subscription

The Mancunian Way: Manky or swanky?

Read the Mancunian Way newsletter for Thursday October 6, 2022.

Manchester Evening News

Hispi and Kala owner Gary Usher raises £126,000 in 12 hours in new restaurant crowdfund

Fans of his business are staking their claim

Manchester Evening News

Why Kala Pharmaceuticals Shares Are Rising Today

Kala Pharmaceuticals Inc (NASDAQ: KALA) shares are trading higher after the company said it would sell its EYSUVIS and INVELTYS treatments for $60 million.

Benzinga

Earnings Preview For Kala Pharmaceuticals

Kala Pharmaceuticals (NASDAQ:KALA) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know before the announcement. Analysts estimate that Kala Pharmaceuticals will report an earnings per share (EPS) of $-0.36.

Benzinga

Kala Pharmaceuticals Posts KPI-012 Data In Healing Impaired Ocular Diseases

Kala Pharmaceuticals Inc (NASDAQ:KALA) reported data from a Phase 1b trial of KPI-012, a cell-free secretome therapy for severe ocular diseases driven by impaired healing. As previously disclosed, KPI-012 was well tolerated and resulted in significant improvements in various persistent corneal epithelial defect (PCED) etiologies. The data will be presented at the 2022…

Benzinga

Kala Pharmaceuticals's Return On Capital Employed Insights

Benzinga Pro data, Kala Pharmaceuticals (NASDAQ:KALA) reported Q4 sales of $1.86 million. Earnings fell to a loss of $47.57 million, resulting in a 69.12% decrease from last quarter.

Benzinga

Recap: Kala Pharmaceuticals Q4 Earnings

Kala Pharmaceuticals (NASDAQ:KALA) reported its Q4 earnings results on Tuesday, March 29, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Earnings Outlook For Kala Pharmaceuticals

Kala Pharmaceuticals (NASDAQ:KALA) is set to give its latest quarterly earnings report on Tuesday, 2022-03-29. Here's what investors need to know before the announcement. Analysts estimate that Kala Pharmaceuticals will report an earnings per share (EPS) of $-0.41.

Benzinga

How To Attend Kala Pharmaceuticals Q4 2021 Earnings Conference Call

Kala Pharmaceuticals (NASDAQ:KALA) will host a conference call at 08:00 AM ET on March 29, 2022, to discuss Q4 2021 earnings results. How to Attend Kala Pharmaceuticals (KALA) Conference Call Follow this link to access the live webcast.

Benzinga

This Microcap Pharma Stock Almost Doubled Today - Read Why

UnitedHealthcare has added Kala Pharmaceuticals Inc's (NASDAQ:KALA) Eysuvis (loteprednol etabonate ophthalmic suspension) 0.25% as a covered brand on its commercial formularies effective March 2022. Eysuvis now has coverage for approximately 118 million lives or 70% of all commercial lives. Kala also announced that Cigna Medicare had added Eysuvis as a preferred brand effective…

Manchester Evening News

Elite Bistros' boss Chef Gary Usher is planning to offer shares in his new business

The boss of Kala and Hispi is opening a new pub too

Get all your
news in one place.

100’s of premium titles.
One news app.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.